←Back to Expert Scholars
Translational Medicine / 转化医学Liquid Biopsy, Asian Cancer Methylation
Bin Tean Teh
MD, PhD
🏢National Cancer Centre Singapore🌐Singapore
Deputy Director
100
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Bin Tean Teh characterizes methylation landscapes of Asian-prevalent cancers and translates them to liquid biopsy assays. His HCC and cholangiocarcinoma programs exemplify regionally tailored early detection. He leads precision oncology at NCCS Singapore.
Share:
🧪Research Fields 研究领域
cfDNA methylation
hepatocellular carcinoma
Asian cancer genomics
cholangiocarcinoma
liquid biopsy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Bin Tean Teh 的研究动态
Follow Bin Tean Teh's research updates
留下邮箱，当我们发布与 Bin Tean Teh（National Cancer Centre Singapore）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment